Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ensysce Biosciences, Inc.ENSC · Entity 8108 | Director · 10% owner | June 23, 2022 | June 27, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ensysce Biosciences, Inc.
Report date June 23, 2022 · Filed June 27, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.43 · Expires 2032-06-23 | Direct | 35,000 |
Reported balance
After 2022-06-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-06-23 · Grant · Acquired 15,000 · Balance 35,000 F1: On June 23, 2022, Mr. Chang was granted an option (the "Stock Option") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year. |
| Common StockSEC Table I · non-derivative | Direct | 353,451 |
Reported balance
Holding disclosure · report date 2022-06-23 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 353,451 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 2,242,189 |
Reported balance
Holding disclosure · report date 2022-06-23 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,242,189 |
Filing footnotes · ownership attribution and instrument terms
F1: On June 23, 2022, Mr. Chang was granted an option (the "Stock Option") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Semler Scientific, Inc.
Report date January 16, 2026 · Filed January 16, 2026
Section 16 reporting ended · disclosed 2026-01-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2026-01-16 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-01-16 · Disposition to issuer · Disposed 428,682 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F2: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Strive Class A common stock equal to 21.05 (the "Exchange Ratio") and cash in lieu of any fractional shares of Strive Class A common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F3: Shares are held by W&D Chang Family Trust. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2026-01-16 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-01-16 · Disposition to issuer · Disposed 154,074 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F2: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Strive Class A common stock equal to 21.05 (the "Exchange Ratio") and cash in lieu of any fractional shares of Strive Class A common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F4: Shares are held in six grantor retained annuity trusts. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2026-01-16 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-01-16 · Disposition to issuer · Disposed 241,508 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F2: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Strive Class A common stock equal to 21.05 (the "Exchange Ratio") and cash in lieu of any fractional shares of Strive Class A common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F5: Shares are held by Chang 2020 GP LP. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.78 · Expires 2036-01-02 | Direct | 0 |
Reported balance
After 2026-01-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-01-16 · Disposition to issuer · Acquired 4,000 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F6: At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time, whether vested or unvested, was converted into an option to purchase, on the same terms and conditions, a number of shares of Strive Class A common stock, rounded down to the nearest whole share, determined by multiplying the number of shares of Issuer common stock subject to such Issuer stock option immediately prior to the Effective Time by the Exchange Ratio, at an exercise price per share of Strive Class A common stock, rounded up to the nearest whole cent, equal to the per share exercise price for the shares of Issuer common stock otherwise purchasable pursuant to such Issuer stock option immediately prior to the Effective Time divided by the Exchange Ratio, and the vesting of the unvested portion of the converted option immediately accelerated as of the Effective Time. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.16 · Expires 2035-05-02 | Direct | 0 |
Reported balance
After 2026-01-16 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-01-16 · Disposition to issuer · Acquired 3,560 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F6: At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time, whether vested or unvested, was converted into an option to purchase, on the same terms and conditions, a number of shares of Strive Class A common stock, rounded down to the nearest whole share, determined by multiplying the number of shares of Issuer common stock subject to such Issuer stock option immediately prior to the Effective Time by the Exchange Ratio, at an exercise price per share of Strive Class A common stock, rounded up to the nearest whole cent, equal to the per share exercise price for the shares of Issuer common stock otherwise purchasable pursuant to such Issuer stock option immediately prior to the Effective Time divided by the Exchange Ratio, and the vesting of the unvested portion of the converted option immediately accelerated as of the Effective Time. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.16 · Expires 2027-05-28 | Direct | 0 |
Reported balance
After 2026-01-16 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-01-16 · Disposition to issuer · Acquired 500 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F6: At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time, whether vested or unvested, was converted into an option to purchase, on the same terms and conditions, a number of shares of Strive Class A common stock, rounded down to the nearest whole share, determined by multiplying the number of shares of Issuer common stock subject to such Issuer stock option immediately prior to the Effective Time by the Exchange Ratio, at an exercise price per share of Strive Class A common stock, rounded up to the nearest whole cent, equal to the per share exercise price for the shares of Issuer common stock otherwise purchasable pursuant to such Issuer stock option immediately prior to the Effective Time divided by the Exchange Ratio, and the vesting of the unvested portion of the converted option immediately accelerated as of the Effective Time. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.94 · Expires 2035-01-06 | Direct | 0 |
Reported balance
After 2026-01-16 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-01-16 · Disposition to issuer · Acquired 7,125 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F6: At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time, whether vested or unvested, was converted into an option to purchase, on the same terms and conditions, a number of shares of Strive Class A common stock, rounded down to the nearest whole share, determined by multiplying the number of shares of Issuer common stock subject to such Issuer stock option immediately prior to the Effective Time by the Exchange Ratio, at an exercise price per share of Strive Class A common stock, rounded up to the nearest whole cent, equal to the per share exercise price for the shares of Issuer common stock otherwise purchasable pursuant to such Issuer stock option immediately prior to the Effective Time divided by the Exchange Ratio, and the vesting of the unvested portion of the converted option immediately accelerated as of the Effective Time. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.94 · Expires 2027-01-29 | Direct | 0 |
Reported balance
After 2026-01-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-01-16 · Disposition to issuer · Acquired 1,000 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F6: At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time, whether vested or unvested, was converted into an option to purchase, on the same terms and conditions, a number of shares of Strive Class A common stock, rounded down to the nearest whole share, determined by multiplying the number of shares of Issuer common stock subject to such Issuer stock option immediately prior to the Effective Time by the Exchange Ratio, at an exercise price per share of Strive Class A common stock, rounded up to the nearest whole cent, equal to the per share exercise price for the shares of Issuer common stock otherwise purchasable pursuant to such Issuer stock option immediately prior to the Effective Time divided by the Exchange Ratio, and the vesting of the unvested portion of the converted option immediately accelerated as of the Effective Time. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.32 · Expires 2026-05-24 | Direct | 0 |
Reported balance
After 2026-01-16 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-01-16 · Disposition to issuer · Acquired 27,000 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F6: At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time, whether vested or unvested, was converted into an option to purchase, on the same terms and conditions, a number of shares of Strive Class A common stock, rounded down to the nearest whole share, determined by multiplying the number of shares of Issuer common stock subject to such Issuer stock option immediately prior to the Effective Time by the Exchange Ratio, at an exercise price per share of Strive Class A common stock, rounded up to the nearest whole cent, equal to the per share exercise price for the shares of Issuer common stock otherwise purchasable pursuant to such Issuer stock option immediately prior to the Effective Time divided by the Exchange Ratio, and the vesting of the unvested portion of the converted option immediately accelerated as of the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger").
F2: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Strive Class A common stock equal to 21.05 (the "Exchange Ratio") and cash in lieu of any fractional shares of Strive Class A common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement.
F3: Shares are held by W&D Chang Family Trust.
F4: Shares are held in six grantor retained annuity trusts.
F5: Shares are held by Chang 2020 GP LP.
F6: At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time, whether vested or unvested, was converted into an option to purchase, on the same terms and conditions, a number of shares of Strive Class A common stock, rounded down to the nearest whole share, determined by multiplying the number of shares of Issuer common stock subject to such Issuer stock option immediately prior to the Effective Time by the Exchange Ratio, at an exercise price per share of Strive Class A common stock, rounded up to the nearest whole cent, equal to the per share exercise price for the shares of Issuer common stock otherwise purchasable pursuant to such Issuer stock option immediately prior to the Effective Time divided by the Exchange Ratio, and the vesting of the unvested portion of the converted option immediately accelerated as of the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2026 Filed Jan 16, 2026 20:18 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | Disposition to issuerStock Option (right to buy) · Derivative | 27,000 | $0.00 Strike: $23.32 | $0.00 |
DisclosureSEC source: 0001104659-26-004501 · tm263164-1_4seq1.xml · derivative · entry 9 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,000 shares Expires 2026-05-24 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F6 · derivative.exercise_date: At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time, whether vested or unvested, was converted into an option to purchase, on the same terms and conditions, a number of shares of Strive Class A common stock, rounded down to the nearest whole share, determined by multiplying the number of shares of Issuer common stock subject to such Issuer stock option immediately prior to the Effective Time by the Exchange Ratio, at an exercise price per share of Strive Class A common stock, rounded up to the nearest whole cent, equal to the per share exercise price for the shares of Issuer common stock otherwise purchasable pursuant to such Issuer stock option immediately prior to the Effective Time divided by the Exchange Ratio, and the vesting of the unvested portion of the converted option immediately accelerated as of the Effective Time. Read SEC document |
| January 16, 2026 Filed Jan 16, 2026 20:18 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | Disposition to issuerStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $58.94 | $0.00 |
DisclosureSEC source: 0001104659-26-004501 · tm263164-1_4seq1.xml · derivative · entry 8 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2027-01-29 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F6 · derivative.exercise_date: At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time, whether vested or unvested, was converted into an option to purchase, on the same terms and conditions, a number of shares of Strive Class A common stock, rounded down to the nearest whole share, determined by multiplying the number of shares of Issuer common stock subject to such Issuer stock option immediately prior to the Effective Time by the Exchange Ratio, at an exercise price per share of Strive Class A common stock, rounded up to the nearest whole cent, equal to the per share exercise price for the shares of Issuer common stock otherwise purchasable pursuant to such Issuer stock option immediately prior to the Effective Time divided by the Exchange Ratio, and the vesting of the unvested portion of the converted option immediately accelerated as of the Effective Time. Read SEC document |
| January 16, 2026 Filed Jan 16, 2026 20:18 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | Disposition to issuerStock Option (right to buy) · Derivative | 7,125 | $0.00 Strike: $58.94 | $0.00 |
DisclosureSEC source: 0001104659-26-004501 · tm263164-1_4seq1.xml · derivative · entry 7 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,125 shares Expires 2035-01-06 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F6 · derivative.exercise_date: At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time, whether vested or unvested, was converted into an option to purchase, on the same terms and conditions, a number of shares of Strive Class A common stock, rounded down to the nearest whole share, determined by multiplying the number of shares of Issuer common stock subject to such Issuer stock option immediately prior to the Effective Time by the Exchange Ratio, at an exercise price per share of Strive Class A common stock, rounded up to the nearest whole cent, equal to the per share exercise price for the shares of Issuer common stock otherwise purchasable pursuant to such Issuer stock option immediately prior to the Effective Time divided by the Exchange Ratio, and the vesting of the unvested portion of the converted option immediately accelerated as of the Effective Time. Read SEC document |
| January 16, 2026 Filed Jan 16, 2026 20:18 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | Disposition to issuerStock Option (right to buy) · Derivative | 500 | $0.00 Strike: $36.16 | $0.00 |
DisclosureSEC source: 0001104659-26-004501 · tm263164-1_4seq1.xml · derivative · entry 6 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2027-05-28 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F6 · derivative.exercise_date: At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time, whether vested or unvested, was converted into an option to purchase, on the same terms and conditions, a number of shares of Strive Class A common stock, rounded down to the nearest whole share, determined by multiplying the number of shares of Issuer common stock subject to such Issuer stock option immediately prior to the Effective Time by the Exchange Ratio, at an exercise price per share of Strive Class A common stock, rounded up to the nearest whole cent, equal to the per share exercise price for the shares of Issuer common stock otherwise purchasable pursuant to such Issuer stock option immediately prior to the Effective Time divided by the Exchange Ratio, and the vesting of the unvested portion of the converted option immediately accelerated as of the Effective Time. Read SEC document |
| January 16, 2026 Filed Jan 16, 2026 20:18 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | Disposition to issuerStock Option (right to buy) · Derivative | 3,560 | $0.00 Strike: $36.16 | $0.00 |
DisclosureSEC source: 0001104659-26-004501 · tm263164-1_4seq1.xml · derivative · entry 5 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,560 shares Expires 2035-05-02 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F6 · derivative.exercise_date: At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time, whether vested or unvested, was converted into an option to purchase, on the same terms and conditions, a number of shares of Strive Class A common stock, rounded down to the nearest whole share, determined by multiplying the number of shares of Issuer common stock subject to such Issuer stock option immediately prior to the Effective Time by the Exchange Ratio, at an exercise price per share of Strive Class A common stock, rounded up to the nearest whole cent, equal to the per share exercise price for the shares of Issuer common stock otherwise purchasable pursuant to such Issuer stock option immediately prior to the Effective Time divided by the Exchange Ratio, and the vesting of the unvested portion of the converted option immediately accelerated as of the Effective Time. Read SEC document |
| January 16, 2026 Filed Jan 16, 2026 20:18 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | Disposition to issuerStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $17.78 | $0.00 |
DisclosureSEC source: 0001104659-26-004501 · tm263164-1_4seq1.xml · derivative · entry 4 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2036-01-02 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F6 · derivative.exercise_date: At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time, whether vested or unvested, was converted into an option to purchase, on the same terms and conditions, a number of shares of Strive Class A common stock, rounded down to the nearest whole share, determined by multiplying the number of shares of Issuer common stock subject to such Issuer stock option immediately prior to the Effective Time by the Exchange Ratio, at an exercise price per share of Strive Class A common stock, rounded up to the nearest whole cent, equal to the per share exercise price for the shares of Issuer common stock otherwise purchasable pursuant to such Issuer stock option immediately prior to the Effective Time divided by the Exchange Ratio, and the vesting of the unvested portion of the converted option immediately accelerated as of the Effective Time. Read SEC document |
| January 16, 2026 Filed Jan 16, 2026 20:18 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | Disposition to issuerCommon Stock | 241,508 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-004501 · tm263164-1_4seq1.xml · nonDerivative · entry 3 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F2 · price: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Strive Class A common stock equal to 21.05 (the "Exchange Ratio") and cash in lieu of any fractional shares of Strive Class A common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F5 · ownership.nature: Shares are held by Chang 2020 GP LP. Read SEC document |
| January 16, 2026 Filed Jan 16, 2026 20:18 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | Disposition to issuerCommon Stock | 154,074 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-004501 · tm263164-1_4seq1.xml · nonDerivative · entry 2 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F2 · price: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Strive Class A common stock equal to 21.05 (the "Exchange Ratio") and cash in lieu of any fractional shares of Strive Class A common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F4 · ownership.nature: Shares are held in six grantor retained annuity trusts. Read SEC document |
| January 16, 2026 Filed Jan 16, 2026 20:18 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | Disposition to issuerCommon Stock | 428,682 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-004501 · tm263164-1_4seq1.xml · nonDerivative · entry 1 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated September 22, 2025 (the "Merger Agreement"), by and among the Issuer, Strive, Inc. ("Strive"), and Strive Merger Sub, Inc., a direct, wholly owned subsidiary of Strive ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer effective as of January 16, 2026 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Strive (the "Merger"). F2 · price: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Strive Class A common stock equal to 21.05 (the "Exchange Ratio") and cash in lieu of any fractional shares of Strive Class A common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F3 · ownership.nature: Shares are held by W&D Chang Family Trust. Read SEC document |
| January 02, 2026 Filed Jan 3, 2026 00:39 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GrantStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $17.78 | $0.00 |
DisclosureSEC source: 0001104659-26-000279 · tm261749-5_4seq1.xml · derivative · entry 1 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2036-01-02 Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:55 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-122125 · tm2533797-1_4seq1.xml · nonDerivative · entry 1 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 428,682 F1 · shares: This transaction involved the reporting person's gift of an aggregate of 60,000 shares of common stock to his grandchildren and other family members not sharing his home. F2 · ownership.nature: Shares are held by W&D Chang Family Trust. Read SEC document |
| May 02, 2025 Filed May 6, 2025 00:25 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GrantStock Option (right to buy) · Derivative | 500 | $0.00 Strike: $36.16 | $0.00 |
DisclosureSEC source: 0001104659-25-044695 · tm2514108-5_4seq1.xml · derivative · entry 2 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 500 shares Expires 2027-05-28 F2 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable as follows: 1/24th of the underlying shares shall vest on the grant date, following which 1/24th of the underlying shares shall vest on a monthly basis thereafter such that all of the underlying shares shall be vested on the second anniversary of the grant date. Read SEC document |
| May 02, 2025 Filed May 6, 2025 00:25 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GrantStock Option (right to buy) · Derivative | 3,560 | $0.00 Strike: $36.16 | $0.00 |
DisclosureSEC source: 0001104659-25-044695 · tm2514108-5_4seq1.xml · derivative · entry 1 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,560 Underlying: Common Stock · 3,560 shares Expires 2035-05-02 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable as follows: 1/12th of the underlying shares shall vest on the grant date, following which 1/12th of the underlying shares shall vest on a monthly basis thereafter such that all of the underlying shares shall be vested on the first anniversary of the grant date. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 22:35 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GrantStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $58.94 | $0.00 |
DisclosureSEC source: 0001104659-25-001745 · tm252129-4_4seq1.xml · derivative · entry 2 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2027-01-29 F2 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable as follows: 1/24th of the underlying shares shall vest on the grant date, following which 1/24th of the underlying shares shall vest on a monthly basis thereafter such that all of the underlying shares shall be vested on the second anniversary of the grant date. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 22:35 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GrantStock Option (right to buy) · Derivative | 7,125 | $0.00 Strike: $58.94 | $0.00 |
DisclosureSEC source: 0001104659-25-001745 · tm252129-4_4seq1.xml · derivative · entry 1 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,125 Underlying: Common Stock · 7,125 shares Expires 2035-01-06 F1 · derivative.exercise_date: The shares underlying the option shall vest and become exercisable as follows: 1/12th of the underlying shares shall vest on the grant date, following which 1/12th of the underlying shares shall vest on a monthly basis thereafter such that all of the underlying shares shall be vested on the first anniversary of the grant date. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 21:15 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 2,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-129375 · tm2431308d2_4seq1.xml · nonDerivative · entry 2 Chang William H · CIK 0001594408 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 439,660 F1 · shares: This transaction involved the reporting person's gift of an aggregate of 2,735 shares of common stock to his grandchildren and other family members. F2 · ownership.nature: Shares are held by W&D Chang Family Trust. Read SEC document |
| November 07, 2024 Filed Nov 12, 2024 11:04 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GrantCommon Stock | 1,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-116121 · tm2427901-2_4seq1.xml · nonDerivative · entry 1 Chang William H · CIK 0001594408 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,500 F1 · shares: Awarded pursuant to the Issuer's non-employee director compensation policy. The shares were fully vested upon grant. Read SEC document |
| November 07, 2024 Filed Jan 7, 2025 22:33 UTC Amendment | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 1,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-001740 · tm252129-6_4aseq1.xml · nonDerivative · entry 3 Chang William H · CIK 0001594408 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 445,895 F2 · ownership.nature: Shares are held by W&D Chang Family Trust. Read SEC document |
| November 07, 2024 Filed Jan 7, 2025 22:33 UTC Amendment | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 1,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-001740 · tm252129-6_4aseq1.xml · nonDerivative · entry 2 Chang William H · CIK 0001594408 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 07, 2024 Filed Jan 7, 2025 22:33 UTC Amendment | Semler Scientific, Inc. SMLR · Entity 69227 | GrantCommon Stock | 1,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-001740 · tm252129-6_4aseq1.xml · nonDerivative · entry 1 Chang William H · CIK 0001594408 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,318 F1 · shares: Awarded pursuant to the Issuer's non-employee director compensation policy. The shares were fully vested upon grant. Read SEC document |
| May 24, 2024 Filed May 29, 2024 20:36 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GrantStock option (right to buy) · Derivative | 27,000 | $0.00 Strike: $23.32 | $0.00 |
DisclosureSEC source: 0001104659-24-066107 · tm2415771-2_4seq1.xml · derivative · entry 1 Chang William H · CIK 0001594408 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2026-05-24 F1 · derivative.exercise_date: This stock option was granted as non-employee director compensation in connection with his appointment to a newly formed committee of the board of directors. The shares underlying the option vest and become exercisable as follows: 1/24th of the underlying shares were immediately vested on the grant date, with the remainder vesting monthly thereafter such that the option is vested in full on April 24, 2026 (one month prior to its expiration date). Read SEC document |
| May 10, 2024 Filed May 15, 2024 01:35 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GrantCommon Stock | 2,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-061359 · tm2414539-4_4seq1.xml · nonDerivative · entry 1 Chang William H · CIK 0001594408 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,182 F1 · shares: Awarded pursuant to the Issuer's non-employee director compensation policy. The shares were fully vested upon grant. Read SEC document |
| May 10, 2024 Filed Jan 7, 2025 22:34 UTC Amendment | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 2,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-001743 · tm252129-7_4aseq1.xml · nonDerivative · entry 2 Chang William H · CIK 0001594408 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 444,577 F2 · ownership.nature: Shares are held by W&D Chang Family Trust. Read SEC document |
| May 10, 2024 Filed Jan 7, 2025 22:34 UTC Amendment | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 2,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-001743 · tm252129-7_4aseq1.xml · nonDerivative · entry 1 Chang William H · CIK 0001594408 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Awarded pursuant to the Issuer's non-employee director compensation policy. The shares were fully vested upon grant. Read SEC document |
| November 04, 2022 Filed Feb 14, 2023 16:32 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 119,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-021716 · tm236827-1_5seq1.xml · nonDerivative · entry 9 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341,991 F3 · ownership.direct: Shares are held directly by William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006. Read SEC document |
| November 04, 2022 Filed Feb 14, 2023 16:32 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 105,582 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-021716 · tm236827-1_5seq1.xml · nonDerivative · entry 8 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F5 · ownership.direct: Shares are held in three GRATs, for which Mrs. Chang acts as sole Trustee and has voting and investment control. Read SEC document |
| November 04, 2022 Filed Feb 14, 2023 16:32 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 105,582 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-021716 · tm236827-1_5seq1.xml · nonDerivative · entry 7 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F4 · ownership.direct: Shares are held in three GRATs, for which Mr. Chang acts as sole Trustee and has voting and investment control. Read SEC document |
| November 02, 2022 Filed Feb 14, 2023 16:32 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-021716 · tm236827-1_5seq1.xml · nonDerivative · entry 6 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,237 F3 · ownership.direct: Shares are held directly by William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006. Read SEC document |
| November 02, 2022 Filed Feb 14, 2023 16:32 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-021716 · tm236827-1_5seq1.xml · nonDerivative · entry 5 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,582 F2 · ownership.direct: Shares held in six GRATs, for which Mrs. Chang acts as sole Trustee and has voting and investment control. Read SEC document |
| November 02, 2022 Filed Feb 14, 2023 16:32 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-021716 · tm236827-1_5seq1.xml · nonDerivative · entry 4 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,582 F1 · ownership.direct: Shares held in six GRATs, for which Mr. Chang acts as sole Trustee and has voting and investment control. Read SEC document |
| September 30, 2022 Filed Feb 14, 2023 16:32 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 238,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-021716 · tm236827-1_5seq1.xml · nonDerivative · entry 3 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 522,237 F3 · ownership.direct: Shares are held directly by William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006. Read SEC document |
| September 30, 2022 Filed Feb 14, 2023 16:32 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 189,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-021716 · tm236827-1_5seq1.xml · nonDerivative · entry 2 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,582 F2 · ownership.direct: Shares held in six GRATs, for which Mrs. Chang acts as sole Trustee and has voting and investment control. Read SEC document |
| September 30, 2022 Filed Feb 14, 2023 16:32 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 189,522 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-021716 · tm236827-1_5seq1.xml · nonDerivative · entry 1 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,582 F1 · ownership.direct: Shares held in six GRATs, for which Mr. Chang acts as sole Trustee and has voting and investment control. Read SEC document |
| June 23, 2022 Filed Jun 27, 2022 17:47 UTC | Ensysce Biosciences, Inc. ENSC · Entity 8108 | GrantStock Option · Derivative | 15,000 | Not disclosed Strike: $0.43 | Not disclosed |
DisclosureSEC source: 0001493152-22-017881 · ownership.xml · derivative · entry 3 Chang William H · CIK 0001594408 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 15,000 shares Expires 2032-06-23 F1 · security: On June 23, 2022, Mr. Chang was granted an option (the "Stock Option") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year. F1 · price: On June 23, 2022, Mr. Chang was granted an option (the "Stock Option") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year. F1 · derivative.exercise_date: On June 23, 2022, Mr. Chang was granted an option (the "Stock Option") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year. Read SEC document |
| February 04, 2022 Filed Feb 4, 2022 15:24 UTC | Ensysce Biosciences, Inc. ENSC · Entity 8108 | GrantStock Option · Derivative | 20,000 | Not disclosed Strike: $3.13 | Not disclosed |
DisclosureSEC source: 0001493152-22-003218 · ownership.xml · derivative · entry 1 Chang William H · CIK 0001594408 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-02-04 F1 · security: On February 4, 2022, Mr. Chang was granted an option (the "Stock Option") to purchase 20,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.01 per share, with an exercise price of $3.13, under the that certain Ensysce Biosciences, Inc. Amended and Restated 2021 Omnibus Incentive Plan. The Stock Option is scheduled to vest on the date of the Company's annual stockholder meeting in 2022. F1 · price: On February 4, 2022, Mr. Chang was granted an option (the "Stock Option") to purchase 20,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.01 per share, with an exercise price of $3.13, under the that certain Ensysce Biosciences, Inc. Amended and Restated 2021 Omnibus Incentive Plan. The Stock Option is scheduled to vest on the date of the Company's annual stockholder meeting in 2022. F1 · derivative.exercise_date: On February 4, 2022, Mr. Chang was granted an option (the "Stock Option") to purchase 20,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.01 per share, with an exercise price of $3.13, under the that certain Ensysce Biosciences, Inc. Amended and Restated 2021 Omnibus Incentive Plan. The Stock Option is scheduled to vest on the date of the Company's annual stockholder meeting in 2022. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 19:14 UTC | Ensysce Biosciences, Inc. ENSC · Entity 8108 | GrantCommon Stock | 2,242,189 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-016122 · ownership.xml · nonDerivative · entry 2 Chang William H · CIK 0001594408 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 2,242,189 F1 · price: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of Ensysce common stock was automatically converted into the right to receive a pro rata portion of 17,334,518 shares of the Issuer's common stock. F3 · ownership.nature: Represents the shares held by the trusts in which the Reporting Person has sole or shared voting and dispositive power. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 19:14 UTC | Ensysce Biosciences, Inc. ENSC · Entity 8108 | GrantCommon Stock | 353,451 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-016122 · ownership.xml · nonDerivative · entry 1 Chang William H · CIK 0001594408 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,451 F1 · price: On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of Ensysce common stock was automatically converted into the right to receive a pro rata portion of 17,334,518 shares of the Issuer's common stock. F2 · ownership.direct: Represents the shares owned jointly with the Reporting Person's wife. Read SEC document |
| June 04, 2021 Filed Jun 4, 2021 19:59 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | SaleCommon Stock | 280 | $110.00 | $30,800.00 |
DisclosureSEC source: 0001104659-21-077240 · tm2118883d1_4.xml · nonDerivative · entry 3 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Chang 2020 Delaware LP · CIK 0001855256 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 412,537 F1 · ownership.nature: Shares are held directly by William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 19:59 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | SaleCommon Stock | 2,720 | $110.82 | $301,419.52 |
DisclosureSEC source: 0001104659-21-077240 · tm2118883d1_4.xml · nonDerivative · entry 2 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Chang 2020 Delaware LP · CIK 0001855256 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 412,817 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $110.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. F1 · ownership.nature: Shares are held directly by William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 19:59 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | SaleCommon Stock | 937 | $110.00 | $103,070.00 |
DisclosureSEC source: 0001104659-21-077240 · tm2118883d1_4.xml · nonDerivative · entry 1 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Chang 2020 Delaware LP · CIK 0001855256 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 415,537 F1 · ownership.nature: Shares are held directly by William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 18:38 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | SaleCommon Stock | 25 | $111.50 | $2,787.50 |
DisclosureSEC source: 0001104659-21-075888 · tm2118323d1_4.xml · nonDerivative · entry 5 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Chang 2020 GP LLC · CIK 0001847364 · 10% owner Chang 2020 Delaware LP · CIK 0001855256 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 416,474 F3 · ownership.nature: Shares are held directly by William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 18:38 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | SaleCommon Stock | 38 | $110.09 | $4,183.60 |
DisclosureSEC source: 0001104659-21-075888 · tm2118323d1_4.xml · nonDerivative · entry 4 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Chang 2020 GP LLC · CIK 0001847364 · 10% owner Chang 2020 Delaware LP · CIK 0001855256 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 416,499 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. F3 · ownership.nature: Shares are held directly by William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 18:38 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | SaleCommon Stock | 1,000 | $110.00 | $110,000.00 |
DisclosureSEC source: 0001104659-21-075888 · tm2118323d1_4.xml · nonDerivative · entry 3 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Chang 2020 GP LLC · CIK 0001847364 · 10% owner Chang 2020 Delaware LP · CIK 0001855256 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 416,537 F3 · ownership.nature: Shares are held directly by William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006. Read SEC document |
| April 19, 2021 Filed Jun 2, 2021 18:38 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-075888 · tm2118323d1_4.xml · nonDerivative · entry 2 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Chang 2020 GP LLC · CIK 0001847364 · 10% owner Chang 2020 Delaware LP · CIK 0001855256 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,416 F2 · ownership.nature: Shares are held by Chang 2020 Delaware LP, for which Mr. and Mrs. Chang are the sole general partners and share voting and investment control. Read SEC document |
| April 19, 2021 Filed Jun 2, 2021 18:38 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-075888 · tm2118323d1_4.xml · nonDerivative · entry 1 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Chang 2020 GP LLC · CIK 0001847364 · 10% owner Chang 2020 Delaware LP · CIK 0001855256 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · ownership.nature: Shares are held by Chang 2020 GP LLC, for which Mr. and Mrs. Chang are the sole managers and share voting and investment control. Read SEC document |
| December 09, 2020 Filed Feb 16, 2021 17:12 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-024373 · tm216980-1_5seq1.xml · nonDerivative · entry 9 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Limited Liability Company Disclosed balance after: 2,416 F4 · ownership.direct: Shares are held by Chang 2020 GP LLC, for which Mr. and Mrs. Chang are the sole managers and share voting and investment control. Read SEC document |
| December 09, 2020 Filed Feb 16, 2021 17:12 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-024373 · tm216980-1_5seq1.xml · nonDerivative · entry 8 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,537 F3 · ownership.direct: Shares are held directly by William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006. Read SEC document |
| December 09, 2020 Filed Mar 31, 2021 17:06 UTC Amendment | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-044855 · tm216980-1_5aseq1.xml · nonDerivative · entry 9 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Chang 2020 GP LLC · CIK 0001847364 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Limited Liability Company Disclosed balance after: 2,416 F4 · ownership.direct: Shares are held by Chang 2020 GP LLC, for which Mr. and Mrs. Chang are the sole managers and share voting and investment control. Read SEC document |
| December 09, 2020 Filed Mar 31, 2021 17:06 UTC Amendment | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 2,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-044855 · tm216980-1_5aseq1.xml · nonDerivative · entry 8 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Chang 2020 GP LLC · CIK 0001847364 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 417,537 F3 · ownership.direct: Shares are held directly by William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006. Read SEC document |
| December 04, 2020 Filed Feb 16, 2021 17:12 UTC | Semler Scientific, Inc. SMLR · Entity 69227 | GiftCommon Stock | 171,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-024373 · tm216980-1_5seq1.xml · nonDerivative · entry 7 William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006 · CIK 0001742975 · 10% owner Chang William H · CIK 0001594408 · 10% owner Chang Diana Shon · CIK 0001793712 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,953 F3 · ownership.direct: Shares are held directly by William H.C. Chang & Diana Shon Chang TTEE Chang Family Trust U/A DTD 10/23/2006. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.